These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 35134140)
1. Categorising Endoscopic Severity of Crohn's Disease Using the Modified Multiplier SES-CD [MM-SES-CD]. Narula N; Pray C; Wong ECL; Colombel JF; Marshall JK; Daperno M; Reinisch W; Dulai PS J Crohns Colitis; 2022 Aug; 16(7):1011-1019. PubMed ID: 35134140 [TBL] [Abstract][Full Text] [Related]
2. Early Reduction in MM-SES-CD Score After Initiation of Biologic Therapy is Highly Specific for 1-year Endoscopic Remission in Moderate to Severe Crohn's Disease. Narula N; Wong ECL; Colombel JF; Sandborn WJ; Ferrante M; Marshall JK; Reinisch W; Dulai PS J Crohns Colitis; 2022 May; 16(4):616-624. PubMed ID: 34664635 [TBL] [Abstract][Full Text] [Related]
3. Predicting endoscopic remission in Crohn's disease by the modified multiplier SES-CD (MM-SES-CD). Narula N; Wong ECL; Colombel JF; Sandborn WJ; Marshall JK; Daperno M; Reinisch W; Dulai PS Gut; 2022 Jun; 71(6):1078-1087. PubMed ID: 33766910 [TBL] [Abstract][Full Text] [Related]
4. Baseline Patient-reported Symptoms Less Predictive Than MM-SES-CD for Endoscopic Remission in Crohn's Disease. Narula N; Wong ECL; Aruljothy A; Dulai PS; Colombel JF; Marshall JK; Ferrante M; Reinisch W J Clin Gastroenterol; 2023 Oct; 57(9):913-919. PubMed ID: 36227009 [TBL] [Abstract][Full Text] [Related]
5. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC. Ferrante M; Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens GR; van der Woude CJ; Danese S; Diamond RH; Oortwijn AF; Tang KL; Miller M; Cornillie F; Rutgeerts PJ; Gastroenterology; 2013 Nov; 145(5):978-986.e5. PubMed ID: 23954314 [TBL] [Abstract][Full Text] [Related]
6. Ulcer Size After Induction Therapy Performs Better Than Symptom Assessment for Prediction of One Year Endoscopic Remission in Crohn's Disease: A Post Hoc Analysis. Pray C; Wong ECL; Aruljothy A; Dulai PS; Marshall JK; Reinisch W; Narula N Inflamm Bowel Dis; 2023 Aug; 29(8):1263-1271. PubMed ID: 36179118 [TBL] [Abstract][Full Text] [Related]
7. The Performance of the Rutgeerts Score, SES-CD, and MM-SES-CD for Prediction of Postoperative Clinical Recurrence in Crohn's Disease. Narula N; Wong ECL; Dulai PS; Marshall JK; Jairath V; Reinisch W Inflamm Bowel Dis; 2023 May; 29(5):716-725. PubMed ID: 35762666 [TBL] [Abstract][Full Text] [Related]
8. Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn's Disease. Danese S; Sandborn WJ; Colombel JF; Vermeire S; Glover SC; Rimola J; Siegelman J; Jones S; Bornstein JD; Feagan BG Gastroenterology; 2019 Oct; 157(4):1007-1018.e7. PubMed ID: 31279871 [TBL] [Abstract][Full Text] [Related]
9. Validating the Simplified Endoscopic Mucosal Assessment for Crohn's Disease: A Novel Method for Assessing Disease Activity. Adler J; Colletti RB; Noonan L; Berzin TM; Cheifetz AS; Conklin LS; Hoops TC; Huang CS; Lewis B; Mishkin DS; Hung Lo K; Xiao Y; Volger S Inflamm Bowel Dis; 2023 Jul; 29(7):1089-1097. PubMed ID: 36049024 [TBL] [Abstract][Full Text] [Related]